Cargando…

Diabetes Mellitus, Glycemic Traits, and Cerebrovascular Disease: A Mendelian Randomization Study

OBJECTIVE: We employed Mendelian randomization to explore the effects of genetic predisposition to type 2 diabetes (T2D), hyperglycemia, insulin resistance, and pancreatic β-cell dysfunction on risk of stroke subtypes and related cerebrovascular phenotypes. METHODS: We selected instruments for genet...

Descripción completa

Detalles Bibliográficos
Autores principales: Georgakis, Marios K., Harshfield, Eric L., Malik, Rainer, Franceschini, Nora, Langenberg, Claudia, Wareham, Nicholas J., Markus, Hugh S., Dichgans, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8055310/
https://www.ncbi.nlm.nih.gov/pubmed/33495378
http://dx.doi.org/10.1212/WNL.0000000000011555
_version_ 1783680427217649664
author Georgakis, Marios K.
Harshfield, Eric L.
Malik, Rainer
Franceschini, Nora
Langenberg, Claudia
Wareham, Nicholas J.
Markus, Hugh S.
Dichgans, Martin
author_facet Georgakis, Marios K.
Harshfield, Eric L.
Malik, Rainer
Franceschini, Nora
Langenberg, Claudia
Wareham, Nicholas J.
Markus, Hugh S.
Dichgans, Martin
author_sort Georgakis, Marios K.
collection PubMed
description OBJECTIVE: We employed Mendelian randomization to explore the effects of genetic predisposition to type 2 diabetes (T2D), hyperglycemia, insulin resistance, and pancreatic β-cell dysfunction on risk of stroke subtypes and related cerebrovascular phenotypes. METHODS: We selected instruments for genetic predisposition to T2D (74,124 cases, 824,006 controls), HbA1c levels (n = 421,923), fasting glucose levels (n = 133,010), insulin resistance (n = 108,557), and β-cell dysfunction (n = 16,378) based on published genome-wide association studies. Applying 2-sample Mendelian randomization, we examined associations with ischemic stroke (60,341 cases, 454,450 controls), intracerebral hemorrhage (1,545 cases, 1,481 controls), and ischemic stroke subtypes (large artery, cardioembolic, small vessel stroke), as well as with related phenotypes (carotid atherosclerosis, imaging markers of cerebral white matter integrity, and brain atrophy). RESULTS: Genetic predisposition to T2D and higher HbA1c levels were associated with higher risk of any ischemic stroke, large artery stroke, and small vessel stroke. Similar associations were also noted for carotid atherosclerotic plaque, fractional anisotropy, a white matter disease marker, and markers of brain atrophy. We further found associations of genetic predisposition to insulin resistance with large artery and small vessel stroke, whereas predisposition to β-cell dysfunction was associated with small vessel stroke, intracerebral hemorrhage, lower gray matter volume, and total brain volume. CONCLUSIONS: This study supports causal effects of T2D and hyperglycemia on large artery and small vessel stroke. We show associations of genetically predicted insulin resistance and β-cell dysfunction with large artery and small vessel stroke that might have implications for antidiabetic treatments targeting these mechanisms. CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that genetic predisposition to T2D and higher HbA1c levels are associated with a higher risk of large artery and small vessel ischemic stroke.
format Online
Article
Text
id pubmed-8055310
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-80553102021-04-20 Diabetes Mellitus, Glycemic Traits, and Cerebrovascular Disease: A Mendelian Randomization Study Georgakis, Marios K. Harshfield, Eric L. Malik, Rainer Franceschini, Nora Langenberg, Claudia Wareham, Nicholas J. Markus, Hugh S. Dichgans, Martin Neurology Article OBJECTIVE: We employed Mendelian randomization to explore the effects of genetic predisposition to type 2 diabetes (T2D), hyperglycemia, insulin resistance, and pancreatic β-cell dysfunction on risk of stroke subtypes and related cerebrovascular phenotypes. METHODS: We selected instruments for genetic predisposition to T2D (74,124 cases, 824,006 controls), HbA1c levels (n = 421,923), fasting glucose levels (n = 133,010), insulin resistance (n = 108,557), and β-cell dysfunction (n = 16,378) based on published genome-wide association studies. Applying 2-sample Mendelian randomization, we examined associations with ischemic stroke (60,341 cases, 454,450 controls), intracerebral hemorrhage (1,545 cases, 1,481 controls), and ischemic stroke subtypes (large artery, cardioembolic, small vessel stroke), as well as with related phenotypes (carotid atherosclerosis, imaging markers of cerebral white matter integrity, and brain atrophy). RESULTS: Genetic predisposition to T2D and higher HbA1c levels were associated with higher risk of any ischemic stroke, large artery stroke, and small vessel stroke. Similar associations were also noted for carotid atherosclerotic plaque, fractional anisotropy, a white matter disease marker, and markers of brain atrophy. We further found associations of genetic predisposition to insulin resistance with large artery and small vessel stroke, whereas predisposition to β-cell dysfunction was associated with small vessel stroke, intracerebral hemorrhage, lower gray matter volume, and total brain volume. CONCLUSIONS: This study supports causal effects of T2D and hyperglycemia on large artery and small vessel stroke. We show associations of genetically predicted insulin resistance and β-cell dysfunction with large artery and small vessel stroke that might have implications for antidiabetic treatments targeting these mechanisms. CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that genetic predisposition to T2D and higher HbA1c levels are associated with a higher risk of large artery and small vessel ischemic stroke. Lippincott Williams & Wilkins 2021-03-30 /pmc/articles/PMC8055310/ /pubmed/33495378 http://dx.doi.org/10.1212/WNL.0000000000011555 Text en Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License 4.0 (CC BY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Article
Georgakis, Marios K.
Harshfield, Eric L.
Malik, Rainer
Franceschini, Nora
Langenberg, Claudia
Wareham, Nicholas J.
Markus, Hugh S.
Dichgans, Martin
Diabetes Mellitus, Glycemic Traits, and Cerebrovascular Disease: A Mendelian Randomization Study
title Diabetes Mellitus, Glycemic Traits, and Cerebrovascular Disease: A Mendelian Randomization Study
title_full Diabetes Mellitus, Glycemic Traits, and Cerebrovascular Disease: A Mendelian Randomization Study
title_fullStr Diabetes Mellitus, Glycemic Traits, and Cerebrovascular Disease: A Mendelian Randomization Study
title_full_unstemmed Diabetes Mellitus, Glycemic Traits, and Cerebrovascular Disease: A Mendelian Randomization Study
title_short Diabetes Mellitus, Glycemic Traits, and Cerebrovascular Disease: A Mendelian Randomization Study
title_sort diabetes mellitus, glycemic traits, and cerebrovascular disease: a mendelian randomization study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8055310/
https://www.ncbi.nlm.nih.gov/pubmed/33495378
http://dx.doi.org/10.1212/WNL.0000000000011555
work_keys_str_mv AT georgakismariosk diabetesmellitusglycemictraitsandcerebrovasculardiseaseamendelianrandomizationstudy
AT harshfieldericl diabetesmellitusglycemictraitsandcerebrovasculardiseaseamendelianrandomizationstudy
AT malikrainer diabetesmellitusglycemictraitsandcerebrovasculardiseaseamendelianrandomizationstudy
AT franceschininora diabetesmellitusglycemictraitsandcerebrovasculardiseaseamendelianrandomizationstudy
AT langenbergclaudia diabetesmellitusglycemictraitsandcerebrovasculardiseaseamendelianrandomizationstudy
AT warehamnicholasj diabetesmellitusglycemictraitsandcerebrovasculardiseaseamendelianrandomizationstudy
AT markushughs diabetesmellitusglycemictraitsandcerebrovasculardiseaseamendelianrandomizationstudy
AT dichgansmartin diabetesmellitusglycemictraitsandcerebrovasculardiseaseamendelianrandomizationstudy